Second Circuit Decision A Reminder that Alleged FDCA violations don’t always equal FCA violations
FDA Law Blog
NOVEMBER 30, 2022
Last month the United States Court of Appeals for the Second Circuit affirmed the district court’s decision to dismiss a False Claims Act (FCA) ( 21 U.S.C In addition, Grifols’s eligibility for government contracts is conditioned on FDA approval of Gamunex and FDA approval is conditioned on compliance with GMPs.
Let's personalize your content